Clinical Outcomes of Resective Surgical Treatment of Peri-Implantitis With or Without Implantoplasty

Stopped early

Conditions studied: Peri-Implantitis

In brief

The aims of the current study are 1) to assess the therapeutic resolution of the peri-implantitis after resective surgical treatment with or without implantoplasty procedure (no further radiographic bone loss, no erythema of the peri-implant mucosa, PD \<6mm), and 2) to evaluate the survival rate of the peri-implantitis treated dental implants.

Key facts

Study ID

NCT04259840

Run by

University of Michigan

People needed

41

Starts

2019-12-05

Expected to finish

2020-07-01

Last updated by the study team

2021-01-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The patient is at least 18 years of age,
• was initially diagnosed with peri-implantitis at ≥1 implant (peri-implant probing depth (PPD) ≥ 6 mm together with bleeding and/or suppuration on probing (BOP/SoP) and bone loss progression over physiological bone remodeling radiologically assessed or marginal bone loss ≥ 3 mm radiologically assessed in case of absence of baseline radiographs),
• had received treatment for peri-implantitis at least 1 year ago at the Graduate Clinic of Periodontics at University of Michigan, and
• documentation from ≥ 1 year of clinical and radiological follow- up is available from U of M patients records.

You may not qualify if…

• Has received or is currently receiving radiotherapy,
• are currently pregnant, unsure of their pregnancy status, or are lactating (as reported by the patient),
• has health condition(s) or takes medication(s) that are known to affect soft tissue or bone (e.g., Phenytoin)
• Received any kind of bone graft during the treatment of the peri-implantitis

Where it is running

• University of Michigan School of Dentistry — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.